Gomez G A, Reese P A, Nava H, Panahon A M, Barcos M, Stutzman L, Han T, Henderson E S
Am J Med. 1984 Aug;77(2):205-10. doi: 10.1016/0002-9343(84)90692-2.
In a prospective randomized study of treatment for early-stage Hodgkin's disease presenting above the diaphragm, 76 patients had staging by laparotomy (Group I) and 28 had staging by closed techniques (Group II). Treatment consisted of involved-field radiotherapy alone (44 patients), involved-field radiotherapy followed by chemotherapy (38 patients), total nodal radiotherapy alone (15 patients), or total nodal radiotherapy followed by chemotherapy (seven patients). On presentation, both groups had similar clinical features and similar treatment distribution. With similar follow-up (87 months), no significant differences in remission or survival were observed between Groups I and II: remission 59 versus 68 percent; survival 74 versus 92 percent; p value 0.27 and 0.09, respectively. Multiple areas of relapse were more frequently observed in Group I (11 of 32 had relapse) as compared with Group II (none of nine had relapse, p less than 0.082). In Group I, relapse in the abdomen was observed as an isolated event or as part of disseminated relapse in 12 percent of patients compared with 3 percent (one patient) in Group II with abdominal relapse alone. Seven patients in Group I and two patients in Group II died with Hodgkin's disease. Six other patients in Group I died with complete remission of non-Hodgkin's lymphoma (one patient), leukoencephalopathy (one patient), sepsis during chemotherapy (two patients), myocardial infarction (one patient), and cerebrovascular accident (one patient). Three other patients in this group had other secondary malignancies successfully controlled (histiocytic lymphoma, squamous cell carcinoma of the cervix, and malignant schwannoma). No second primary lesions or death with complete remission were observed in Group II. Staging laparotomy with splenectomy in early-stage Hodgkin's disease did not improve the duration of remission or survival or decrease the number of abdominal relapses compared with closed staging.
在一项针对横膈以上早期霍奇金病治疗的前瞻性随机研究中,76例患者通过剖腹术进行分期(第一组),28例通过闭合技术进行分期(第二组)。治疗包括单纯累及野放疗(44例患者)、累及野放疗后化疗(38例患者)、单纯全淋巴结放疗(15例患者)或全淋巴结放疗后化疗(7例患者)。初诊时,两组具有相似的临床特征和相似的治疗分布。随访时间相似(87个月),第一组和第二组在缓解率或生存率方面未观察到显著差异:缓解率分别为59%和68%;生存率分别为74%和92%;p值分别为0.27和0.09。与第二组(9例中无复发,p<0.082)相比,第一组更频繁地观察到多个复发部位(32例中有11例复发)。在第一组中,12%的患者腹部复发表现为孤立事件或作为播散性复发的一部分,而第二组仅1例(3%)患者出现腹部复发。第一组7例患者和第二组2例患者死于霍奇金病。第一组另外6例患者死于非霍奇金淋巴瘤完全缓解(1例)、白质脑病(1例)、化疗期间败血症(2例)、心肌梗死(1例)和脑血管意外(1例)。该组另外3例患者有其他继发性恶性肿瘤得到成功控制(组织细胞淋巴瘤、宫颈鳞状细胞癌和恶性神经鞘瘤)。第二组未观察到第二原发性病变或完全缓解状态下的死亡。与闭合分期相比,早期霍奇金病行分期剖腹术加脾切除术并未改善缓解期或生存期,也未减少腹部复发的数量。